Oncology & Cancer

ART era has changed secondary cancers after Kaposi sarcoma

(HealthDay)—There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma (KS) in the era of highly-active antiretroviral therapy (HAART), according to a study published online Aug. 24 in JAMA ...

Oncology & Cancer

Children, parents over-report leukemia treatment adherence

New research suggests that young patients with acute lymphocytic leukemia (ALL)—the most common type of pediatric cancer—and their and their parents are likely to report to their physician that they took more of their ...

Oncology & Cancer

Herpes virus linked to most common type of childhood cancer

Newborns with congenital cytomegalovirus (CMV)—a common virus in the herpes family—may have an increased risk of developing acute lymphocytic leukemia (ALL), according to new research published online today in Blood, ...

Oncology & Cancer

New immune Tx achieves remission in B-cell malignancies

(HealthDay)—A new T-cell immunotherapy has led to sustained regression in many previously relapsing and treatment-resistant cases of acute lymphoblastic leukemia, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia, ...

Oncology & Cancer

Cancer treatments got gentler, yet kids' survival improved

The move to make cancer treatments gentler for children has paid a double dividend: More kids are surviving than ever before, and without the long-term complications that doomed many of their peers a generation ago, new research ...

page 3 from 5